Cours suspendu

Communiqués LAVA Therapeutics

Actions

LVTX

NL0015000AG6

Recherche biotechnologique et médicale

Temps Différé Nasdaq Autres places de cotation 22:00:00 20/11/2025			Varia. 5j.	Varia. 1 janv.
1,740 ^USD	-3,87%		-.--%	-

21/11	Xoma Royalty finalise l'acquisition de Lava Therapeutics	MT
21/11	Xoma Royalty annonce la finalisation de l'acquisition de Lava Therapeutics N.V.	RE

Communiqués

13/11	LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq	AQ
10/11	LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline	AQ
30/09/25	LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025	AQ
13/08/25	LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update	AQ
14/05/25	LAVA Reports First Quarter 2025 Financial Results, Provides Business Update	AQ
16/04/25	LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation	AQ
28/03/25	LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update	AQ
25/02/25	LAVA Announces Evaluation of Strategic Options	AQ
13/01/25	LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers	AQ
10/01/25	LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers	AQ
10/12/24	LAVA Therapeutics N : Consolidated Financial Statements Form 6 K	PU
10/12/24	LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027	AQ
03/09/24	LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	AQ
20/08/24	LAVA Reports Second Quarter 2024 Financial Results and Business Update	AQ
20/06/24	LAVA Therapeutics N : Results of Annual General Meeting of Shareholders Form 6 K	PU
20/06/24	LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference	AQ
20/06/24	LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference	GL
10/06/24	LAVA Announces Annual Meeting of Shareholders	GL
30/05/24	LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference	GL
21/05/24	LAVA Therapeutics N : Form 6-K	PU
21/05/24	LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results	GL
06/05/24	LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference	AQ
06/05/24	LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference	GL
20/03/24	LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results	AQ
20/03/24	LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results	GL